Sex and Racial Disparities in Catheter Ablation

Overview

Journal Heart Rhythm O2

Date 2023 Jan 2

PMID 36589007

Authors

Bert Vandenberk

Derek S Chew

Ratika Parkash

Anne M Gillis

Affiliations

Soon will be listed here.

Abstract

Sex and racial disparities in the presentation, diagnosis, and management of cardiac arrhythmias are recognized. Sex-specific differences in electrophysiological parameters are well known and are predominantly related to differences in ion channel expression and the influence of sex hormones. However, the relationship between hormonal or racial influence and arrhythmia mechanisms, presentation, and management needs to be better defined. Women and racial and ethnic groups are less likely to undergo catheter ablation procedures for treatment of cardiac arrhythmias. Underrepresentation of women and racial/ethnic groups in clinical trials has resulted in significant knowledge gaps. Whether sex and racial disparities in arrhythmia management reflect barriers in access to care, physician bias, patient values, and preferences or other factors requires further study.

Citing Articles

Special issue on electrophysiology and arrhythmia management around the globe: Challenges and opportunities explored.

Srivatsa U Heart Rhythm O2. 2023; 3(6Part B):720-722.

PMID: 36589012 PMC: 9795310. DOI: 10.1016/j.hroo.2022.10.016.

References

Fernandez-Armenta J, Soto-Iglesias D, Silva E, Penela D, Jauregui B, Linhart M . Safety and Outcomes of Ventricular Tachycardia Substrate Ablation During Sinus Rhythm: A Prospective Multicenter Registry. JACC Clin Electrophysiol. 2020; 6(11):1435-1448. DOI: 10.1016/j.jacep.2020.07.028. View

Odening K, Koren G . How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity. Heart Rhythm. 2014; 11(11):2107-15. PMC: 4394187. DOI: 10.1016/j.hrthm.2014.06.023. View

Cheung J, Cheng E, Wu X, Yeo I, Christos P, Kamel H . Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14. Eur Heart J. 2019; 40(36):3035-3043. PMC: 7963138. DOI: 10.1093/eurheartj/ehz151. View

Freedman L, Simon R, Foulkes M, Friedman L, Geller N, Gordon D . Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists. Control Clin Trials. 1995; 16(5):277-85; discussion 286-9, 293-309. DOI: 10.1016/0197-2456(95)00048-8. View

Reddy V, Reynolds M, Neuzil P, Richardson A, Taborsky M, Jongnarangsin K . Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007; 357(26):2657-65. PMC: 2390777. DOI: 10.1056/NEJMoa065457. View

Sapp J, Wells G, Parkash R, Stevenson W, Blier L, Sarrazin J . Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med. 2016; 375(2):111-21. DOI: 10.1056/NEJMoa1513614. View

Busch S, Forkmann M, Kuck K, Lewalter T, Ince H, Straube F . Acute and long-term outcome of focal atrial tachycardia ablation in the real world: results of the german ablation registry. Clin Res Cardiol. 2018; 107(5):430-436. DOI: 10.1007/s00392-018-1204-8. View

Eberly L, Garg L, Yang L, Markman T, Nathan A, Eneanya N . Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation. JAMA Netw Open. 2021; 4(2):e210247. PMC: 7910819. DOI: 10.1001/jamanetworkopen.2021.0247. View

Van Spall H, Lala A, Deering T, Casadei B, Zannad F, Kaul P . Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. J Am Coll Cardiol. 2021; 77(23):2960-2972. DOI: 10.1016/j.jacc.2021.04.038. View

10.

Al-Khatib S, Daubert J, Anstrom K, Daoud E, Gonzalez M, Saba S . Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2014; 26(2):151-7. DOI: 10.1111/jce.12567. View

11.

Konig S, Ueberham L, Muller-Rothing R, Wiedemann M, Ulbrich M, Sause A . Catheter ablation of ventricular arrhythmias and in-hospital mortality: insights from the German-wide Helios hospital network of 5052 cases. Europace. 2019; 22(1):100-108. DOI: 10.1093/europace/euz260. View

12.

Ferguson J, Tierney W, Westmoreland G, Mamlin L, Segar D, Eckert G . Examination of racial differences in management of cardiovascular disease. J Am Coll Cardiol. 1997; 30(7):1707-13. DOI: 10.1016/s0735-1097(97)00365-3. View

13.

Lip G, Laroche C, Boriani G, Cimaglia P, Dan G, Santini M . Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace. 2014; 17(1):24-31. DOI: 10.1093/europace/euu155. View

14.

Kuo L, Shirai Y, Muser D, Liang J, Castro S, Santangeli P . Comparison of the arrhythmogenic substrate between men and women with nonischemic cardiomyopathy. Heart Rhythm. 2019; 16(9):1414-1420. DOI: 10.1016/j.hrthm.2019.03.024. View

15.

Kelsey M, Patrick-Lake B, Abdulai R, Broedl U, Brown A, Cohn E . Inclusion and diversity in clinical trials: Actionable steps to drive lasting change. Contemp Clin Trials. 2022; 116:106740. PMC: 9133187. DOI: 10.1016/j.cct.2022.106740. View

16.

Magnussen C, Niiranen T, Ojeda F, Gianfagna F, Blankenberg S, Njolstad I . Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation. 2017; 136(17):1588-1597. PMC: 5657474. DOI: 10.1161/CIRCULATIONAHA.117.028981. View

17.

Eitel C, Ince H, Brachmann J, Kuck K, Willems S, Spitzer S . Catheter ablation of supraventricular tachycardia in patients with and without structural heart disease: insights from the German ablation registry. Clin Res Cardiol. 2021; 111(5):522-529. PMC: 9054935. DOI: 10.1007/s00392-021-01878-z. View

18.

Noubiap J, Thomas G, Agbaedeng T, Fitzgerald J, Gallagher C, Middeldorp M . Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States. Eur Heart J Qual Care Clin Outcomes. 2021; 8(8):852-860. DOI: 10.1093/ehjqcco/qcab096. View

19.

Deneke T, Muller P, Lawo T, Lemke B, Horlitz M, Calcum B . Gender differences in onset of symptoms in AV nodal re-entrant and accessory pathway-mediated re-entrant tachycardia. Herzschrittmacherther Elektrophysiol. 2009; 20(1):33-8. DOI: 10.1007/s00399-009-0036-7. View

20.

Gillis A . Atrial Fibrillation and Ventricular Arrhythmias: Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes. Circulation. 2017; 135(6):593-608. DOI: 10.1161/CIRCULATIONAHA.116.025312. View